Jeanett Holzknecht, M.Sc., PhD student
Email: jeanett.holzknecht@i-med.ac.at
Phone: +43/(0)512/9003-70220
Fax: +43/(0)512-9003-73100
Short curriculum
2010-2014 | Bachelor studies in Biology at the Leopold-Franzens-University, Innsbruck |
2014-2016 | Master studies in Microbiology, Leopold-Franzens-University, Innsbruck |
2016-2017 | Master thesis at the Division of Molecular Biology, Biocenter, Medical University Innsbruck; Title: The impact of heme on the pathogen Aspergillus fumigatus |
since 2017 | PhD thesis at the Division of Molecular Biology, Biocenter, Medical University Innsbruck |
Research fields
Antifungal proteins in filamentous fungi - Applied Mycology
Internatoinal Congresses
Power of Microbes in Industry and Enviroment 2019, 15 May -18 May 2019, Kroatien
Poster: Small, cysteine-rich, cationic proteins from Penicillium chrysogenum are promising antifungal therapeutic molecules to treat fungal skin infections
18th International Congress of the Hungarian Society for Microbiology, 03 July - 05 July 2019, Ungarn
Poster: PAFC: the third small, cysteine-rich, cationic antifungal protein from Penicillium chrysogenum effectively inhibits the growth of Candida albicans
Publikations
- Kovács R, Holzknecht J, Hargitai Z, Papp C, Farkas A, Borics A, Tóth L, Váradi G, Tóth GK, Kovács I, Dubrac S, Majoros L, Marx F, Galgóczy L. (2019). In vivo applicability of Neosartorya fischeri antifungal protein 2 (nfap2) in treatment of vulvovaginal candidiasis. Antimicrob. AgentsChemother.63(2)
- Hetzer B, Orth-Höller D, Würzner R, Kreidl P, Lackner M, Müller T, Knabl L, Geisler-Moroder DR, Mellmann A, Sesli Ö, Holzknecht J, Noce D, Boonpala O, Akarathum N, Chotinaruemol S, Prelog M, Oberdorfer P. (2019) "Enhanced acquisition of antibiotic-resistant intestinal E. coli during the first year of life assessed in a prospective cohort study". Antimicrob Resist Infect Control 8:79
- Huber A, Galgóczy L, Váradi G, Holzknecht J, Kakar A, Malanovic N, Leber R, Koch J, Keller MA, Batta G, Tóth GK, Marx F. (2020) Two small, cysteine-rich and cationic antifungal proteins from Penicillium chrysogenum: A comparative study of PAF and PAFB. Biochim Biophys Acta Biomembr. 1862(8):183246.
- Holzknecht J, Kühbacher A, Papp C, Farkas A, Váradi G, Marcos JF, Manzanares P, Tóth GK, Galgóczy L, Marx F. (2020) The Penicillium chrysogenum Q176 Antimicrobial Protein PAFC Effectively Inhibits the Growth of the Opportunistic Human Pathogen Candida albicans. J Fungi (Basel). 6(3):141.